This review will summarize recent research findings and discuss the therapeutic potential of selected NRs in acute and chronic myeloid leukemia, focusing on RAR, VDR, PPAR, and retinoid X receptor (RXR). The gene discussed is VDR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.